✦ LIBER ✦

Bevacizumab + folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell’ Italia Meridionale (prot. GOIM 2601)

✍ Scribed by F. Giuliani; V. Lorusso; F. De Vita; S. Cinieri; E. Maiello; I. Nugnes; S. del Prete; M. Orditura; S. Leo; R. Addeo; G. Colucci

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Folfiri versus xeliri in untreated advan

✍ F. Giuliani; F. De Vita; E. Maiello; I. Nugnes; M. Di Bisceglie; S. Romito; V. L 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Epirubicin, taxotere and fluorouracil mo

✍ F. Giuliani; S. Romito; E. Maiello; A. Capobianco; F. Carrozza; I. Nugnes; A. Mi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Bevacizumab&#xa0;+&#xa0;folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell’ Italia Meridionale (prot. GOIM 2601)